Zobrazeno 1 - 3
of 3
pro vyhledávání: '"C J Arri"'
Autor:
James O. Kahn, A Bostrom, John G. Gambertoglio, R Williams, G Gatti, K J Gorelick, C J Arri, J D Lifson
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:260-267
GLQ223 is a highly purified single-chain ribosome-inactivating protein with selective effects against a variety of cells, including macrophages infected with human immunodeficiency virus. We evaluated the safety, pharmacokinetics, and immunologic eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de27f9ca7a03dc0346ee352bd517f08f
https://doi.org/10.1128/aac.38.2.260
https://doi.org/10.1128/aac.38.2.260
Autor:
L M Bouvier, T L Hodges, J Mordenti, James O. Kahn, A J Amman, C J Arri, Jerome E. Groopman, A E Izu, Lawrence D. Kaplan, Paul A. Volberding
Publikováno v:
Antimicrobial Agents and Chemotherapy. 35:2580-2586
The safety and pharmacokinetics of recombinant CD4-immunoglobulin G (rCD4-IgG) were evaluated in a phase 1 study with dose escalation. A total of 16 patients, 6 with AIDS and 10 with AIDS-related complex, were evaluated at two university-affiliated h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26ea2b0a1bb19635312db602d6da9180
https://doi.org/10.1128/aac.35.12.2580
https://doi.org/10.1128/aac.35.12.2580
Autor:
T L Hodges, Lawrence D. Kaplan, C J Arri, H F Fitch, J D Allan, James O. Kahn, Jerome E. Groopman, A E Izu, J E Sherwin, J Mordenti
Publikováno v:
Annals of Internal Medicine. 112:254
Study Objective:To evaluate the safety and pharmacokinetics of recombinant, soluble human CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d2c7a46606464b592a11cc4ae5d91a8
https://doi.org/10.7326/0003-4819-112-4-
https://doi.org/10.7326/0003-4819-112-4-